iSpecimen (ISPC) Income from Continuing Operations (2020 - 2026)
iSpecimen (ISPC) posted quarterly Income from Continuing Operations of 2652125.0 for Q1 2026, down 46.26% year-over-year from 4935436.21 in Q1 2025, and up 7.65% quarter-over-quarter from 2871925.0 in Q4 2025.
iSpecimen (ISPC) Income from Continuing Operations (2020 - 2026) Analysis & Trends
iSpecimen's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 2652125.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 46.26% year-over-year to 2652125.0; the TTM figure through Mar 2026 stood at 10519307.0 (up 17.56% YoY), while the FY2025 annual figure was 9663113.0, up 31.84% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2652125.0, up from 2871925.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1711533.0 in Q3 2024, with the low at 6305844.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 2829933.0 (2025), against an average of 2909354.65.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations tumbled 110.81% in 2022, then jumped 54.46% in 2025.
- iSpecimen's Income from Continuing Operations stood at 2082297.0 in 2022, then slumped by 52.1% to 3167156.0 in 2023, then plunged by 99.1% to 6305844.0 in 2024, then soared by 54.46% to 2871925.0 in 2025, then increased by 7.65% to 2652125.0 in 2026.
- Business Quant data shows ISPC's Income from Continuing Operations at 2652125.0 in Q1 2026, 2871925.0 in Q4 2025, and 2829933.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | -1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.36 Mn |
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.83 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Sep 30, 2024 | -1.71 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -3.38 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Sep 30, 2023 | -2.13 Mn |
| Jun 30, 2023 | -3.58 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -2.16 Mn |
| Sep 30, 2022 | -3.10 Mn |
| Jun 30, 2022 | -2.61 Mn |
| Mar 31, 2022 | -2.38 Mn |
| Dec 31, 2021 | -2.03 Mn |
| Sep 30, 2021 | -1.55 Mn |